Article
The Roles of MDM2 and MDMX in Cancer
29 Mar 2016
Abstract excerpt
For more than 25 years, MDM2 and its homolog MDMX (also known as MDM4) have been shown to exert oncogenic activity. These two proteins are best understood as negative regulators of the p53 tumor suppressor, although they may have additional p53-independent roles. Understanding the dysregulation of MDM2 and MDMX in human cancers and how they function either together or separately in tumorigenesis may improve...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
